1. To evaluate if patients with chronic kidney disease and a high risk of progression, urate-lowering treatment with allopurinol.
2. To determine clinical significance of study results.
Friday, March 5, 2021 - 12:00pm to 1:00pm
5700 S. Maryland
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Juhi Bhargava, MD